These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8536853)

  • 1. A longitudinal analysis of hepatitis C virus replication following liver transplantation.
    Gane EJ; Naoumov NV; Qian KP; Mondelli MU; Maertens G; Portmann BC; Lau JY; Williams R
    Gastroenterology; 1996 Jan; 110(1):167-77. PubMed ID: 8536853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus recurrence after liver transplantation: relationship to anti-HCV core IgM, genotype, and level of viremia.
    Crespo J; Carte B; Lozano JL; Casafont F; Rivero M; de la Cruz F; Pons-Romero F
    Am J Gastroenterol; 1997 Sep; 92(9):1458-62. PubMed ID: 9317062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver biopsy, viral kinetics, and the impact of viremia on severity of hepatitis C virus recurrence.
    Charlton M
    Liver Transpl; 2003 Nov; 9(11):S58-62. PubMed ID: 14586897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term longitudinal study of intrahepatic hepatitis C virus replication after liver transplantation.
    Di Martino V; Saurini F; Samuel D; Gigou M; Dussaix E; Reynès M; Bismuth H; Féray C
    Hepatology; 1997 Nov; 26(5):1343-50. PubMed ID: 9362382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
    Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation.
    Féray C; Gigou M; Samuel D; Paradis V; Mishiro S; Maertens G; Reynés M; Okamoto H; Bismuth H; Bréchot C
    Gastroenterology; 1995 Apr; 108(4):1088-96. PubMed ID: 7698576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus genotypes and quantitation of serum hepatitis C virus RNA in liver transplant recipients: relationship with severity of histological recurrence and implications in the pathogenesis of HCV infection.
    Pageaux GP; Ducos J; Mondain AM; Costes V; Picot MC; Perrigault PF; Domergue J; Larrey D; Michel H
    Liver Transpl Surg; 1997 Sep; 3(5):501-5. PubMed ID: 9346792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of viral genotype and level of viremia on the severity of liver injury and the response to interferon therapy in Spanish patients with chronic C infection.
    Fernández I; Castellano G; Domingo MJ; Fuertes A; Colina F; Canga F; de la Cruz FJ; de la Cámara AG; Solís JA
    Scand J Gastroenterol; 1997 Jan; 32(1):70-6. PubMed ID: 9018770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of intrahepatic hepatitis C virus replication by strand-specific semi-quantitative RT-PCR: preliminary application to the liver transplantation model.
    Negro F; Giostra E; Krawczynski K; Quadri R; Rubbia-Brandt L; Mentha G; Colucci G; Perrin L; Hadengue A
    J Hepatol; 1998 Jul; 29(1):1-11. PubMed ID: 9696486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative liver parameters of HCV infection: relation to HCV genotypes, viremia and response to interferon treatment.
    Ballardini G; Manzin A; Giostra F; Francesconi R; Groff P; Grassi A; Solforosi L; Ghetti S; Zauli D; Clementi M; Bianchi FB
    J Hepatol; 1997 Apr; 26(4):779-86. PubMed ID: 9126789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low HCV replication levels in end-stage hepatitis C virus-related liver disease.
    Duvoux C; Pawlotsky JM; Bastie A; Cherqui D; Soussy CJ; Dhumeaux D
    J Hepatol; 1999 Oct; 31(4):593-7. PubMed ID: 10551380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
    Arnold JC; Töx U; Goeser T; Otto G; Müller HM; Hofmann WJ; Stremmel W; Theilmann L
    Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
    Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
    Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent hepatitis C virus infection after liver transplantation: immunohistochemical assessment of the viral antigen.
    Vargas V; Krawczynski K; Castells L; Martinez N; Esteban J; Allende H; Esteban R; Guardia J
    Liver Transpl Surg; 1998 Jul; 4(4):320-7. PubMed ID: 9649647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of hepatitis C infection after liver transplantation.
    Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R
    N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of liver hepatitis C virus RNA and hepatitis C virus genotype on FAS-mediated apoptosis after liver transplantation for hepatitis C.
    Di Martino V; Brenot C; Samuel D; Saurini F; Paradis V; Reynés M; Bismuth H; Féray C
    Transplantation; 2000 Nov; 70(9):1390-6. PubMed ID: 11087158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus genotypes and quantification of serum hepatitis C RNA in liver transplant recipients. Relationship with histologic outcome of recurrent hepatitis C.
    Costes V; Durand L; Pageaux GP; Ducos J; Mondain AM; Picot MC; Domergue J; Larrey D; Baldet P
    Am J Clin Pathol; 1999 Feb; 111(2):252-8. PubMed ID: 9930149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretransplant virological markers hepatitis C virus genotype and viremia level are not helpful in predicting individual outcome after orthotopic liver transplantation.
    Berg T; Hopf U; Bechstein WO; Müller AR; Fukumoto T; Neuhaus R; Lobeck H; Neuhaus P
    Transplantation; 1998 Jul; 66(2):225-8. PubMed ID: 9701269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-hepatitis C virus core IgM antibodies correlate with hepatitis C recurrence and its severity in liver transplant patients.
    Bizollon T; Ahmed SN; Guichard S; Chevallier P; Adham M; Ducerf C; Baulieux J; Trepo C
    Gut; 2000 Nov; 47(5):698-702. PubMed ID: 11034588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia.
    Zhou S; Terrault NA; Ferrell L; Hahn JA; Lau JY; Simmonds P; Roberts JP; Lake JR; Ascher NL; Wright TL
    Hepatology; 1996 Nov; 24(5):1041-6. PubMed ID: 8903372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.